A Phase III Study of CS1003 in Subjects With Advanced Hepatocellular Carcinoma

Condition:   Hepatocellular Carcinoma Interventions:   Drug: CS1003+Lenvatinib;   Drug: CS1003 Placebo+Lenvatinib Sponsor:   CStone Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials